Winship treats first lung cancer patient with T-cell receptor

As National Cancer Act turns 50, Winship Cancer Institute reflects on progress

Clinical Updates in Non-Small Cell Lung Cancer from Madrid - A Clinical Updates Activity - Integrity CE

Bortezomib enhances cytotoxicity of ex vivo-expanded gamma delta T cells against acute myeloid leukemia and T-cell acute lymphoblastic leukemia - Cytotherapy

Winship Weekly Winship Cancer Institute

Pharmacological rescue of tumor intrinsic STING expression and immune response in LKB1-mutant lung cancer via the IAP-JAK regulatory axis

History of Winship Winship Cancer Institute

Articles and Media Releases - Archive

Articles and Media Releases - Archive

History of Winship Winship Cancer Institute

Mirage or long-awaited oasis: reinvigorating T-cell responses in pancreatic cancer. - Abstract - Europe PMC

Winship advances cancer cellular therapy, Emory University

Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment - ScienceDirect